Hospitals are reaching capacity as the aggressive new flu strain is spreading fast across the US and globally.
India's hospital chains, diagnostics networks, and global investors have poured millions of dollars into gene sequencing, ...
Biomarker Therapy in 2025: More Lung Cancer Options, Competition in New Drug Classes, ctDNA Advances
This year, there was a surge of new lung cancer treatments, more options for patients with earlier-stage disease, and growing evidence on the utility of ctDNA testing.
A team at the University of Macau aimed to develop a novel peptide targeting the tumor necrosis factor (TNF)-TNFR2 interaction as a selective regulatory T cell (Treg) stimulator. Through phage display ...
Six individuals, including an investment banker, face multiple U.S. charges stemming from an alleged $41 million insider-trading scheme, plus stock manipulation schemes involving biopharma companies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results